| USD ($) $ in Millions, shares in Millions | LTM | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues: | ||||||||||||||||||
Premiums | $ 352,307 | $ 352,229 | $ 308,810 | $ 290,827 | ||||||||||||||
Products | - | - | - | - | ||||||||||||||
Services | - | - | - | - | ||||||||||||||
Investment and other income | 4,133 | 3,920 | 5,202 | 4,089 | ||||||||||||||
Total revenues | 450,129 | 447,567 | 400,278 | 371,622 | ||||||||||||||
Operating costs: | ||||||||||||||||||
Medical costs | 310,846 | 313,995 | 264,185 | 241,894 | ||||||||||||||
Operating costs | 61,878 | 59,592 | 53,013 | 54,628 | ||||||||||||||
Cost of products sold | 51,444 | 50,655 | 46,694 | 38,770 | ||||||||||||||
Depreciation and amortization | 4,285 | 4,361 | 4,099 | 3,972 | ||||||||||||||
Total operating costs | 428,453 | 428,603 | 367,991 | 339,264 | ||||||||||||||
Earnings from operations | 21,676 | 18,964 | 32,287 | 32,358 | ||||||||||||||
Interest expense | (3,894) | (4,002) | (3,906) | (3,246) | ||||||||||||||
Loss on sale of subsidiary and subsidiaries held for sale | (342) | (265) | (8,310) | - | ||||||||||||||
Total income before income taxes | 17,440 | 14,697 | 20,071 | 29,112 | ||||||||||||||
Provision for income taxes | 2,528 | 1,890 | 4,829 | 5,968 | ||||||||||||||
Net earnings | 14,912 | 12,807 | 15,242 | 23,144 | ||||||||||||||
Earnings attributable to noncontrolling interests | 790 | 751 | 837 | 763 | ||||||||||||||
Net earnings attributable to UnitedHealth Group common shareholders | $ 14,122 | $ 12,056 | $ 14,405 | $ 22,381 | ||||||||||||||
Earnings per share attributable to UnitedHealth Group common shareholders: | ||||||||||||||||||
Basic | $ 15.6 | $ 13.28 | $ 15.64 | $ 24.12 | ||||||||||||||
Diluted | 15.56 | 13.23 | 15.51 | 23.86 | ||||||||||||||
Basic weighted-average number of common shares outstanding | 905 | 908 | 921 | 928 | ||||||||||||||
Dilutive effect of common share equivalents | 2 | 3 | 8 | 10 | ||||||||||||||
Diluted weighted-average number of common shares outstanding | 908 | 911 | 929 | 938 | ||||||||||||||
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents | 17 | 12 | 6 | 6 | ||||||||||||||
Cash dividends per common share | - | - | - | - | ||||||||||||||
Cash dividends declared per common share | - | - | - | - |